UNRESECTABLE GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for UNRESECTABLE GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet finished but already full! 3 Completed 1

New drug duo tested in fight against tough stomach cancers

Disease control Completed

This study tested a combination of two drugs, olaparib and ramucirumab, for people with advanced stomach or esophageal junction cancers that had spread, returned, or could not be removed by surgery. The main goals were to find a safe dose and see if the combination could shrink t…

Matched conditions: UNRESECTABLE GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

UNRESECTABLE GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new UNRESECTABLE GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New drug duo tested in fight against tough stomach cancers